Document is current
Any future updates will be listed below
-
Authors
Lerma-Irureta, David
Presa-Gutiérrez, Elsa
Méndez-López, Fátima
Vicente-García, Carmen
Blasco-González, Isabel
Magallón-Botaya, Rosa
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI22/01070)
- License Information
-
More Information
Article History
Received: 4 May 2026
Accepted: 18 June 2026
First Online: 24 June 2026
Declarations
:
: The ARALONGCOV project and this secondary analysis were conducted in accordance with the Declaration of Helsinki and were approved by the Ethics Committee for Clinical Research of Aragon (CEICA; reference PI21/278). All participants provided written informed consent before inclusion in the parent study.
: Not applicable.
: The authors declare no competing interests.
